As a result of the disappointing results, Boehringer said that it was abandoning a long-term extension trial called CONNEX-X, ...

Interleukin-1 (IL-1) is a key molecule involved in inflammation and plays an important role in both healthy and diseased ...

Wikenigma describes itself as "a wiki-based resource specifically dedicated to documenting fundamental gaps in human ...

A comprehensive study mapped neuronal IL-1R1 (nIL-1R1) expression in the mouse brain, highlighting its role in sensory ...

Riluzole treatment and a diet containing high glycemic index foods interact 'synergistically' to slow ALS progression, ...

The study uncovers hippocampal neurons that differentially respond to sugars and fats, suggesting new avenues for combating ...

A recent study has made significant strides in uncovering how the oral microbiome, particularly the bacterium Fusobacterium ...

Butovsky believes xenon has potential as an AD treatment. A Phase 1 clinical trial of xenon at BWH is recruiting healthy elderly volunteers to test safety and effects on immune cells. “I hope this ...

Researchers from Hunan University and Nankai University have made advancement in the field of aqueous zinc batteries (AZBs). Published in National ...

Interleukin-1 (IL-1) is a key molecule involved in inflammation and plays an important role in both healthy and diseased states. In disease, high ...

SORL1 dysfunction messes with endosomes in neurons, and with lysosomes in microglia.

Addex Therapeutics Ltd (NASDAQ:ADXN – Get Free Report) was the recipient of a large drop in short interest during the month of December. As of December 31st, there was short interest totalling 5,700 ...